Furthermore, if genetic variants such as C9orf72 are directly contributing to the exercise ‘dose’ which can be tolerated prior to incidence, then previous studies, not measuring variants, will have overestimated the effects of exercise on ALS incidence in sporadic patients, undermining protective effects. This evidence concerns the gene C9orf72 and amyotrophic lateral sclerosis.